Datwyler opens pharmaceutical components plant in US

Middletown, Delaware – Datwylers Sealing Solutions has opened a new production plant for pharmaceutical components in Middletown, Delaware.

The CHF100-million (€88.1 million) production facility, said the Swiss company in a 28-Sept statement, operates to Datwyler’s ‘first line’ standard, based on advanced cleanroom technology, automated production, camera inspection and special cleaning processes.

Products include high-quality elastomer components for the growing biotech and pharmaceutical markets. The company expects to carry out certification by customers in the fourth quarter of 2018 and start series production at the beginning of 2019.

The facility…

To read more,please login or register below.

This is the first step to more free
content, user offers, subscriptions
and more.
Log in here using the Email Address
and Password you signed up with